 cost-effect antitrypsin replac therapi treatment congenit chronic obstruct pulmonari diseas background alpha aat replac therapi expens intervent patient progress chronic obstruct pulmonari diseas copd aat-defici patient fda-approv therapi efficaci unknown cost benefit aat replac therapi patient congenit copd method epidemiolog diseas cost data sourc discrete-tim model diseas stage probabl transit present-valu expect cost diseas treatment rang possibl therapi efficaci paramet valu result efficaci percent cost life year aat replac therapi US dollar patient age sex smoke statu percent efficaci cost life year rang control efficaci studi true efficaci percent conclus efficaci percent therapi cost-effect compar medic intervent econom assess methodolog therapeut innov valu addit clinic research